Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
July 30, 2023
Share
Fukuda Denshi Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the period, the company expected net sales of JPY 130,000 million, operating profit of JPY 20,000 million, profit attributable to owners of parent of JPY 14,000 million and basic earnings per share of JPY 462.80.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.